Perfusate enzymes after cold storage and reperfusion
Cell-based study · isolated perfused rat liver model [1]
In an isolated perfused rat liver model, Caftaric acid-supplemented livers underwent static cold storage followed by reperfusion. Perfusate ALT, AST, and LDH levels were significantly lower than in the vehicle control group.
| Endpoint | Reported result | Reference |
|---|---|---|
| AST, ALT and LDH in perfusate samples | Reported result 50 µM; After 48 h of SCS followed by 2 h of reperfusion, perfusates from CA-supplemented livers exhibited significantly lower levels of ALT, AST, and LDH than those from the vehicle control group. | [1] |
Literature-Reported Treatment Conditions
- Exposure duration
- 48 h of SCS followed by 2 h of reperfusion
- Method
- CA-supplemented livers
- Co-treatment
- Other interventions in this design: static cold storage (SCS) and reperfusion. Compound effect isolated by the comparison: vehicle control group.
- Reported limits
- Not stated in the sentences used: dose, vehicle.
Methods and source locations
Compound reported in the paper: Caftaric acid
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Caftaric Acid alleviates liver cold ischemia/reperfusion injury induced by extended cold ischemia time (S109, S113, S114, S121, S122)
AST, ALT and LDH in perfusate samples: AST, ALT and LDH in perfusate samples; comparator: vehicle control group — Results > Caftaric Acid alleviates liver cold ischemia/reperfusion injury induced by extended cold ischemia time (S109, S114, S122)